ENFN 250117 12.50C (ENFN250117C12500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ENFN250117C12500

Watchlist

0.60
0.000.00%

15min DelayClose Dec 31 16:00 ET

0.70High0.55Low

Intraday

5D
Daily

News

This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
BenzingaDec 30, 2024 07:45 ET
Enfusion (NYSE:ENFN) Will Be Hoping To Turn Its Returns On Capital Around
Simply Wall StDec 28, 2024 07:33 ET
Piper Sandler Maintains Neutral on Enfusion, Raises Price Target to $11.5
BenzingaDec 23, 2024 07:28 ET · Ratings
Piper Sandler Maintains Enfusion(ENFN.US) With Hold Rating, Raises Target Price to $11.5
Moomoo NewsDec 23, 2024 05:31 ET · Ratings
Enfusion (ENFN) Receives a Hold From Piper Sandler
TipRanksDec 23, 2024 04:56 ET · Ratings
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
BenzingaDec 19, 2024 16:06 ET

Comments

snowman91

20 hours ago

M&A target Jan/Feb 2025

$Enfusion (ENFN.US)$ this will be bought out anytime soon, looking at price action and options flow

Moomoo AI

Mar 13, 2024 06:45

Enfusion's decent ROE doesn't translate into growth due to a five-year net income decline. High payout ratio or poor capital allocation might be hampering growth. Despite high ROE and profit retention, earnings growth is below expectations, indicating possible external threats.

Has Enfusion, Inc.'s (NYSE:ENFN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Movers and Shakers

Jan 30, 2024 07:14

Columns Today's Morning Movers and Top Ratings: GM, SMCI, UPS, SPOT and More

Morning Movers
Gapping up
$General Motors (GM.US)$ stock soared 7.8% after the auto giant reported lower pretax profit for the fourth quarter but gave investors an upbeat outlook for 2024 and signaled more capital could be returned to shareholders.
$Pfizer (PFE.US)$ stock rose 1.1% after the drugmaker reported a surprise quarterly profit, helped by COVID products demand being stronger than expectations and lower research costs.
$Ford Motor (F.US)$ stock ros...

Moomoo AI

Jan 4, 2024 04:27

Enfusion's ROCE shows a worrisome downward trend despite sales growth and reinvestment. Efficiency in generating ROCE may be on a decline as the company increasingly funds operations with its own money.

Enfusion (NYSE:ENFN) Is Reinvesting At Lower Rates Of Return

Moomoo AI

Oct 31, 2023 09:40

Enfusion's current trading price suggests a potential to buy low. However, due to low volatility and other fiscal factors, ENFN's intrinsic value may take time to reach, possibly limiting future low-price buying chances. Its high growth potential at a cheap price makes it a compelling investment.

When Should You Buy Enfusion, Inc. (NYSE:ENFN)?